トランスフェクション試薬・機器市場：製品、方法、用途、エンドユーザー別-2025-2030年世界予測

トランスフェクション試薬・機器市場は、2023年に24億8,000万米ドルと評価され、2024年には27億9,000万米ドルに達すると予測され、CAGR 12.76％で成長し、2030年には57億6,000万米ドルに達すると予測されています。

トランスフェクション試薬と装置は、遺伝子の機能を研究したりタンパク質を生産したりするために、細胞に核酸を導入するために不可欠です。トランスフェクションの範囲は、遺伝子治療、がん研究、タンパク質合成における重要な応用を確実にするため、研究室や臨床研究室にわたるさまざまな技術やユーティリティをカバーしています。これらのツールは、医学研究やバイオテクノロジー開発の進展に不可欠です。その必要性は、遺伝子工学で提供される精度と効率にあり、個別化医療、創薬、バイオテクノロジーの進歩を促進します。この市場の最終用途には、学術研究機関、バイオテクノロジー企業、製薬業界、臨床研究機関などが含まれ、それぞれが独自の用途ニーズで需要を牽引しています。

主な成長要因としては、ライフサイエンスにおける研究開発投資の急増、精密医療への注目の高まり、遺伝子疾患研究の急増などが挙げられます。技術の急速な進歩はトランスフェクション技術の自動化を促進し、効率向上の新たな機会を提供しています。しかし、装置や試薬に関連する高コスト、複雑な規制の枠組み、特定の細胞株におけるトランスフェクション剤の効率制限などが市場成長の課題となっており、普及の妨げとなる可能性があります。新たなビジネスチャンスは、よりコスト効率が高く毒性の低いトランスフェクション法の開発や、CRISPR-Cas9のような遺伝子編集技術への応用拡大にあります。

新興国市場への進出、トランスフェクション効率を高めるための新規試薬製剤の研究開発への投資、技術進歩のための共同研究などに注力することが、事業成長の革新的な道筋となります。少数の有力企業と多数の小規模なニッチ企業という市場の競争特性を理解することは、戦略的ポジショニングの指針となります。企業は、世界の消費者動向に合わせて、製品開発において環境に優しく持続可能な慣行を優先することが推奨されます。顧客教育イニシアチブを強化することにより、複雑なトランスフェクション技術を簡略化し、エンドユーザーによる幅広い採用を促進することもできます。これらの戦略を取り入れることで、企業は固有の成長課題を軽減しながら、市場の潜在力を活用することができます。

市場力学：急速に進化するトランスフェクション試薬・機器市場の主要市場インサイトを公開

トランスフェクション試薬・機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 細胞科学分野における研究活動の活発化
  • 世界のがん罹患率の増加
  • 組換えタンパク質の迅速な生成のための哺乳類細胞の大規模トランスフェクション
• 市場抑制要因
  • 培地中の血清および細胞コンフルエントがトランスフェクション効率に及ぼす影響
• 市場機会
  • トランスフェクション技術における最近の進歩
  • 製薬会社およびバイオテクノロジー企業による研究開発および施設拡張活動の増加
• 市場の課題
  • より高い生物学的安全性の維持

ポーターのファイブフォース：トランスフェクション試薬・機器市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：トランスフェクション試薬・機器市場における外部からの影響の把握

外部マクロ環境要因は、トランスフェクション試薬・機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析トランスフェクション試薬・機器市場における競合情勢の把握

トランスフェクション試薬・機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックストランスフェクション試薬・機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、トランスフェクション試薬・機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 細胞科学分野における調査活動の活発化
    • 世界中でがんの罹患率が増加
    • 組換えタンパク質のより迅速な生成のための哺乳類細胞の大規模トランスフェクション
  • 抑制要因
    • 培地中の血清と細胞密度がトランスフェクション効率に与える影響
  • 機会
    • トランスフェクション技術の最近の進歩
    • 製薬・バイオテクノロジー企業による研究開発と設備拡張活動の増加
  • 課題
    • 生物学的安全性のより高いレベルの維持
• 市場セグメンテーション分析
  • 製品：遺伝物質の送達を促進または強化するためのトランスフェクション試薬の使用の増加
  • エンドユーザー：製薬会社およびバイオテクノロジー企業におけるワクチンおよび遺伝子治療の開発におけるトランスフェクション試薬・機器の高い可能性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 トランスフェクション試薬・機器市場：製品別

• 装置
• 試薬

第7章 トランスフェクション試薬・機器市場：方法別

• 生化学的方法
  • リン酸カルシウム
  • デキストラン
  • デンドリマー
  • リポフェクション
• 物理的方法
  • エレクトロポレーション
  • ジェネガン
  • マグネトフェクション
  • ヌクレオフェクション
  • オプトインジェクション
  • ソノポレーション
• ウイルスによる方法
  • アデノ随伴ウイルス
  • アデノウイルス
  • レトロウイルス

第8章 トランスフェクション試薬・機器市場：用途別

• 生物調査
• タンパク質生産
• 治療の実施

第9章 トランスフェクション試薬・機器市場：エンドユーザー別

• 学術機関および調査機関
• 製薬・バイオテクノロジー企業

第10章 南北アメリカのトランスフェクション試薬・機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のトランスフェクション試薬・機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのトランスフェクション試薬・機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ポリプラス、新たなDOEサービスオプションを備えたFectoVIR-LVトランスフェクション試薬を発売
  • 肺を標的としたトランスフェクション試薬は生体分子の安全かつ効果的な送達を提供する
  • ザルトリウス、細胞・遺伝子治療市場における地位強化のためポリプラスを買収

企業一覧

• BioVision, Inc.
• Qiagen N.V.
• Lonza Group Ltd.
• Altogen Biosystems
• IBA Lifesciences GmbH
• GeneCopoeia, Inc.
• F. Hoffmann-La Roche AG
• Agilent Technologies, Inc.
• MaxCyte, Inc.
• Mirus Bio LLC
• SBS Genetech Co., Ltd.
• Active Motif, Inc.
• TransGen Biotech Co., Ltd.
• Tecan Trading AG
• Bex Co., Ltd.
• Bio-Rad Laboratories, Inc.
• Applied Biological Materials Inc.
• Merck KGaA
• Polyplus-Transfection SA by Sartorius AG
• Promega Corporation
• PerkinElmer, Inc.
• Takara Bio Inc.
• Danaher Corporation
• Fugent, LLC
• Sutter Instrument Co.
• OriGene Technologies Inc.
• Thermo Fisher Scientific Inc.
• Omega Bio-tek, Inc.
• Sartorius AG

LIST OF FIGURES

• FIGURE 1. TRANSFECTION REAGENTS & EQUIPMENT MARKET RESEARCH PROCESS
• FIGURE 2. TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. TRANSFECTION REAGENTS & EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. TRANSFECTION REAGENTS & EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TRANSFECTION REAGENTS & EQUIPMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TRANSFECTION REAGENTS & EQUIPMENT MARKET DYNAMICS
• TABLE 7. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DEAE-DEXTRAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DENDRIMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY LIPOFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENEGUN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAGNETOFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY NUCLEOFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY OPTOINJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SONOPORATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ADENOASSOCIATED VIRUSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ADENOVIRUSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY RETROVIRUSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY THERAPEUTIC DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 61. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 62. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 63. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 64. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 98. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 99. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 100. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 101. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 105. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 106. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 107. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 108. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 225. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 226. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 227. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 228. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 251. POLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 252. POLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 253. POLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 254. POLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 255. POLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 256. POLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. POLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 258. QATAR TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. QATAR TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 260. QATAR TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 261. QATAR TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 262. QATAR TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 263. QATAR TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. QATAR TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOCHEMICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY VIRAL METHODS, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND TR

The Transfection Reagents & Equipment Market was valued at USD 2.48 billion in 2023, expected to reach USD 2.79 billion in 2024, and is projected to grow at a CAGR of 12.76%, to USD 5.76 billion by 2030.

Transfection reagents and equipment are essential for introducing nucleic acids into cells, either to study gene function or to produce proteins. The scope of transfection covers a range of techniques and utilities across research and clinical laboratories, ensuring critical applications in gene therapy, cancer research, and protein synthesis. These tools are indispensable for advancing medical research and biotechnological developments. Their necessity lies in the precision and efficiency offered in genetic engineering, facilitating advancements in personalized medicine, drug discovery, and biotechnology. The end-use scope of this market encompasses academic research institutions, biotechnology companies, pharmaceutical industries, and clinical research organizations, each driving demand with unique application needs.

Key growth influencers include the escalating R&D investments in life sciences, a growing focus on precision medicine, and the surge in genetic disorder studies. Rapid advancements in technology are fostering automation in transfection technologies, offering new opportunities for efficiency gain. However, market growth is challenged by high costs associated with equipment and reagents, complex regulatory frameworks, and limited transfection agent efficiency in certain cell lines, which could hinder widespread adoption. Emerging opportunities lie in developing more cost-effective and less toxic transfection methods and expanding applications in gene editing technologies like CRISPR-Cas9.

Innovative avenues for business growth are underscored by expanding into developing markets, investing in R&D for novel reagent formulations to increase transfection efficiency, and focusing on collaborations for technology advancement. Understanding the market's competitive nature, characterized by a few dominant players and numerous small niche companies, can guide strategic positioning. Companies are recommended to prioritize eco-friendly and sustainable practices in product development to align with global consumer trends. Enhanced customer education initiatives can also facilitate broader end-user adoption by simplifying complex transfection techniques. By embracing these strategies, businesses can position themselves to harness the market's potential while mitigating inherent growth challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transfection Reagents & Equipment Market

The Transfection Reagents & Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising Research Activities in the Field of Cell Science
  • Growing Prevalence of Cancer Worldwide
  • Large-Scale Transfection of Mammalian Cells for the Faster Generation of Recombinant Protein
• Market Restraints
  • Effect of Serum in Media and Cell Confluency on Efficiency of Transfection
• Market Opportunities
  • Recent Advancements in Transfection Technology
  • Increasing R&D and Facility Expansion Activities by Pharmaceutical and Biotech Companies
• Market Challenges
  • Maintenance of Higher Level of Biological Safety

Porter's Five Forces: A Strategic Tool for Navigating the Transfection Reagents & Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transfection Reagents & Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transfection Reagents & Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transfection Reagents & Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transfection Reagents & Equipment Market

A detailed market share analysis in the Transfection Reagents & Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transfection Reagents & Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transfection Reagents & Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Transfection Reagents & Equipment Market, highlighting leading vendors and their innovative profiles. These include BioVision, Inc., Qiagen N.V., Lonza Group Ltd., Altogen Biosystems, IBA Lifesciences GmbH, GeneCopoeia, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Inc., MaxCyte, Inc., Mirus Bio LLC, SBS Genetech Co., Ltd., Active Motif, Inc., TransGen Biotech Co., Ltd., Tecan Trading AG, Bex Co., Ltd., Bio-Rad Laboratories, Inc., Applied Biological Materials Inc., Merck KGaA, Polyplus-Transfection SA by Sartorius AG, Promega Corporation, PerkinElmer, Inc., Takara Bio Inc., Danaher Corporation, Fugent, LLC, Sutter Instrument Co., OriGene Technologies Inc., Thermo Fisher Scientific Inc., Omega Bio-tek, Inc., and Sartorius AG.

Market Segmentation & Coverage

This research report categorizes the Transfection Reagents & Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Equipment and Reagents.
• Based on Method, market is studied across Biochemical Methods, Physical Methods, and Viral Methods. The Biochemical Methods is further studied across Calcium Phosphate, Deae-Dextran, Dendrimers, and Lipofection. The Physical Methods is further studied across Electroporation, Genegun, Magnetofection, Nucleofection, Optoinjection, and Sonoporation. The Viral Methods is further studied across Adenoassociated Viruses, Adenoviruses, and Retroviruses.
• Based on Application, market is studied across Biomedical Research, Protein Production, and Therapeutic Delivery.
• Based on End User, market is studied across Academics & Research Institutes and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Research Activities in the Field of Cell Science
    • 5.1.1.2. Growing Prevalence of Cancer Worldwide
    • 5.1.1.3. Large-Scale Transfection of Mammalian Cells for the Faster Generation of Recombinant Protein
  • 5.1.2. Restraints
    • 5.1.2.1. Effect of Serum in Media and Cell Confluency on Efficiency of Transfection
  • 5.1.3. Opportunities
    • 5.1.3.1. Recent Advancements in Transfection Technology
    • 5.1.3.2. Increasing R&D and Facility Expansion Activities by Pharmaceutical and Biotech Companies
  • 5.1.4. Challenges
    • 5.1.4.1. Maintenance of Higher Level of Biological Safety
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing usage of transfection reagents to facilitate or enhance the delivery of genetic materials
  • 5.2.2. End User: High potential of transfection reagents & equipment across pharmaceutical & biotechnology companies for the development of vaccines and gene therapies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Transfection Reagents & Equipment Market, by Product

• 6.1. Introduction
• 6.2. Equipment
• 6.3. Reagents

7. Transfection Reagents & Equipment Market, by Method

• 7.1. Introduction
• 7.2. Biochemical Methods
  • 7.2.1. Calcium Phosphate
  • 7.2.2. Deae-Dextran
  • 7.2.3. Dendrimers
  • 7.2.4. Lipofection
• 7.3. Physical Methods
  • 7.3.1. Electroporation
  • 7.3.2. Genegun
  • 7.3.3. Magnetofection
  • 7.3.4. Nucleofection
  • 7.3.5. Optoinjection
  • 7.3.6. Sonoporation
• 7.4. Viral Methods
  • 7.4.1. Adenoassociated Viruses
  • 7.4.2. Adenoviruses
  • 7.4.3. Retroviruses

8. Transfection Reagents & Equipment Market, by Application

• 8.1. Introduction
• 8.2. Biomedical Research
• 8.3. Protein Production
• 8.4. Therapeutic Delivery

9. Transfection Reagents & Equipment Market, by End User

• 9.1. Introduction
• 9.2. Academics & Research Institutes
• 9.3. Pharmaceutical & Biotechnology Companies

10. Americas Transfection Reagents & Equipment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Transfection Reagents & Equipment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Transfection Reagents & Equipment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Polyplus Launches FectoVIR-LV Transfection Reagent with New DOE Service Options
  • 13.3.2. Lungs-Targeted Transfection Reagent Offers Safe and Effective Delivery of Biomolecules
  • 13.3.3. Sartorius to Acquire Polyplus to Strengthen its Position in the Cell and Gene Therapy Market

Companies Mentioned

• 1. BioVision, Inc.
• 2. Qiagen N.V.
• 3. Lonza Group Ltd.
• 4. Altogen Biosystems
• 5. IBA Lifesciences GmbH
• 6. GeneCopoeia, Inc.
• 7. F. Hoffmann-La Roche AG
• 8. Agilent Technologies, Inc.
• 9. MaxCyte, Inc.
• 10. Mirus Bio LLC
• 11. SBS Genetech Co., Ltd.
• 12. Active Motif, Inc.
• 13. TransGen Biotech Co., Ltd.
• 14. Tecan Trading AG
• 15. Bex Co., Ltd.
• 16. Bio-Rad Laboratories, Inc.
• 17. Applied Biological Materials Inc.
• 18. Merck KGaA
• 19. Polyplus-Transfection SA by Sartorius AG
• 20. Promega Corporation
• 21. PerkinElmer, Inc.
• 22. Takara Bio Inc.
• 23. Danaher Corporation
• 24. Fugent, LLC
• 25. Sutter Instrument Co.
• 26. OriGene Technologies Inc.
• 27. Thermo Fisher Scientific Inc.
• 28. Omega Bio-tek, Inc.
• 29. Sartorius AG